Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.82M | Sell |
4,850
-1,840
| -28% | -$1.88M | 1.41% | 23 |
|
|
2026
Q1 | $6.15M | Buy |
6,690
+902
| +16% | +$914K | 1.6% | 17 |
|
|
2025
Q4 | $6.22M | Buy |
5,788
+2,755
| +91% | +$2.63M | 1.53% | 20 |
|
|
2025
Q3 | $2.31M | Sell |
3,033
-373
| -11% | -$278K | 0.84% | 46 |
|
|
2025
Q2 | $2.65M | Sell |
3,406
-1,645
| -33% | -$1.28M | 1.04% | 39 |
|
|
2025
Q1 | $4.17M | Sell |
5,051
-3,421
| -40% | -$2.85M | 1.78% | 15 |
|
|
2024
Q4 | $6.54M | Sell |
8,472
-6,312
| -43% | -$5.23M | 2% | 11 |
|
|
2024
Q3 | $13.1M | Sell |
14,784
-7,388
| -33% | -$6.64M | 2.39% | 6 |
|
|
2024
Q2 | $20.1M | Sell |
22,172
-21,432
| -49% | -$17.1M | 3.15% | 1 |
|
|
2024
Q1 | $33.9M | Sell |
43,604
-13,302
| -23% | -$9.47M | 3.04% | 1 |
|
|
2023
Q4 | $33.2M | Sell |
56,906
-1,635
| -3% | -$954K | 2.9% | 3 |
|
|
2023
Q3 | $31.4M | Buy |
58,541
+18,294
| +45% | +$9.43M | 2.52% | 12 |
|
|
2023
Q2 | $18.9M | Sell |
40,247
-24,839
| -38% | -$10.4M | 1.42% | 30 |
|
|
2023
Q1 | $22.4M | Sell |
65,086
-18,359
| -22% | -$6.19M | 1.47% | 29 |
|
|
2022
Q4 | $30.5M | Sell |
83,445
-8,654
| -9% | -$3.07M | 2.02% | 15 |
|
|
2022
Q3 | $29.8M | Sell |
92,099
-18,551
| -17% | -$5.88M | 2.08% | 16 |
|
|
2022
Q2 | $35.9M | Sell |
110,650
-73,636
| -40% | -$22.1M | 2.25% | 13 |
|
|
2022
Q1 | $52.8M | Sell |
184,286
-24,715
| -12% | -$6.36M | 2.65% | 3 |
|
|
2021
Q4 | $57.7M | Sell |
209,001
-27,467
| -12% | -$6.96M | 2.6% | 3 |
|
|
2021
Q3 | $54.6M | Buy |
236,468
+19,116
| +9% | +$4.72M | 2.32% | 6 |
|
|
2021
Q2 | $49.9M | Buy |
217,352
+114,334
| +111% | +$23M | 2% | 13 |
|
|
2021
Q1 | $19.2M | Buy |
103,018
+99,981
| +3,292% | +$19.6M | 0.82% | 52 |
|
|
2020
Q4 | $513K | Buy |
3,037
+141
| +5% | +$21.1K | 0.02% | 143 |
|
|
2020
Q3 | $429K | Buy |
+2,896
| New | +$448K | 0.02% | 139 |
|
|
2019
Q3 | – | Sell |
-7,053
| Closed | -$781K | – | 129 |
|
|
2019
Q2 | $781K | Buy |
7,053
+961
| +16% | +$113K | 0.04% | 90 |
|
|
2019
Q1 | $790K | Sell |
6,092
-10,651
| -64% | -$1.3M | 0.04% | 110 |
|
|
2018
Q4 | $1.94M | Buy |
+16,743
| New | +$1.87M | 0.09% | 102 |
|
|
2018
Q2 | – | Sell |
-32,945
| Closed | -$2.55M | – | 154 |
|
|
2018
Q1 | $2.55M | Buy |
32,945
+1,280
| +4% | +$103K | 0.1% | 116 |
|
|
2017
Q4 | $2.67M | Buy |
31,665
+3,363
| +12% | +$286K | 0.12% | 107 |
|
|
2017
Q3 | $2.42M | Buy |
28,302
+10,554
| +59% | +$866K | 0.09% | 108 |
|
|
2017
Q2 | $1.46M | Buy |
+17,748
| New | +$1.45M | 0.05% | 117 |
|
Other funds holding LLY
TOBAM's LLY Position: Q2 2026 in Review
TOBAM reduced its Eli Lilly (LLY) stake by 28% in Q2 2026, selling an estimated $1.88M and leaving 4,850 shares worth $5.82M. The position accounts for 1.41% of the portfolio, ranked #23.
TOBAM first reported a position in LLY in Q2 2017 and has held it in 31 quarters since. The position peaked at $57.7M in Q4 2021. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- TOBAM held 4,850 shares of Eli Lilly worth $5.82M as of Q2 2026.
- TOBAM sold 1,840 Eli Lilly shares in Q2 2026, an estimated $1.88M.
- Eli Lilly made up 1.41% of TOBAM's portfolio in Q2 2026, its #23 holding.
- TOBAM first reported a position in Eli Lilly in Q2 2017 and has held it in 31 quarters since.
- TOBAM's Eli Lilly position peaked at $57.7M in Q4 2021.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on TOBAM's 13F filing for Q2 2026, filed 31 Jul 2026.